Clips / Mushrooms for the Mind & Immune System | Paul Stamets
This is why, again, I want to say we have to be adults in the room about this.
0:34 · 1:27:12–1:27:46 in the episode · Paul Stamets
“This is why, again, I want to say we have to be adults in the room about this.”
In context
Full transcript →-
before they were anxious about dying?
-
And now they're saying, you know, family, chill out.
-
It's okay.
-
I know what's going on here.
-
And surprisingly, many of them are not dying.
-
No clinical trial has been done on this,
-
but when you're happier, your immune system upregulates.
-
When you're depressed, you have an inflammatory state,
-
your immune system down regulates.
-
So its mind over body clearly has an effect.
-
So the therapeutic element that you mentioned is absolutely critical.
-
This is why, again, I want to say we have to be adults in the room about this.
-
These are powerful medicines.
-
These are not party drugs.
-
We need regulation.
-
I mean, it's surprisingly coming from me, but we need regulation.
-
Because the dangers of not having regulation and purity and the therapeutic regimen,
-
we don't want to fumble the ball on this.
-
It's too much potential good for society.
-
Yeah. Well, I'll just say, and here I want to be clear, I'm revealing my personal bias, but with all the cautionary points that came up earlier in mind, amen to that. It's kind of ironic that the fastest movement that we've observed for the psychedelics, in particular, Ibogaine, and psilocybin presumably will be next and a non-psychedelic, the empathogen MDMA, moving to FDA approval. They're not there yet, but it seems like they're
-
headed there quickly, has been through this alliance between, let's just call it what it is,
-
the left and the right.